Corpus ID: 30874559

The Evidence-Base for Neurofeedback as a Reimbursable Healthcare Service to Treat Attention Deficit/Hyperactivity Disorder

@inproceedings{Pigott2012TheEF,
  title={The Evidence-Base for Neurofeedback as a Reimbursable Healthcare Service to Treat Attention Deficit/Hyperactivity Disorder},
  author={Ed Pigott and L. D. Biase and Eugenia Bodenhamer-Davis and R. E. Davis},
  year={2012}
}
a Ed Pigott, Ph.D. is a licensed psychologist and Director of Neurotherapy Services at Behavioral Health of the Palm Beaches. He is also in private practice at The Center for Brain Training in Jupiter, FL. b Lindsay De Biase, Ph.D. is a neuroscientist and post-doctoral fellow. C Eugenia Bodenhamer-Davis, Ph.D. is an Associate Professor and Director, Neurotherapy Program, University of North Texas and a Board member of the Biofeedback Certification International Alliance. D Richard E. Davis, M.S… Expand
6 Citations

Figures and Tables from this paper

References

SHOWING 1-10 OF 90 REFERENCES
The Effectiveness of Neurofeedback and Stimulant Drugs in Treating AD/HD: Part II. Replication
  • 83
  • PDF
A Review of Neurofeedback Treatment for Pediatric ADHD
  • 163
Neurofeedback for Children with ADHD: A Comparison of SCP and Theta/Beta Protocols
  • 186
  • PDF
Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial.
  • 354
  • PDF
Neurofeedback in ADHD: a single-blind randomized controlled trial
  • 142
  • PDF
...
1
2
3
4
5
...